Diabetes Care Drugs Market Size, Status and Forecast 2021- Novo Nordisk, Sanofi, Eli Lilly, Takeda, Pfizer, Janssen Pharmaceuticals, Astellas

The report presents an in-depth assessment of the Global Diabetes Care Drugs including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Global Diabetes Care Drugs investments from 2020 till 2024.

The market size, in 2017, for the global diabetes drugs market was registered to be USD 67,510.43 million, and the market is expected to record a CAGR of 5.65% during the forecast period, 2019-2024.

Request for PDF Brochure:

https://www.marketinsightsreports.com/reports/04021169140/diabetes-care-drugs-market-2012-2024/inquiry?Mode=21

North America dominates the market, followed by Asia-Pacific. Diabetes or diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate or one does not produce insulin (known as Type 1 diabetes), or because the body's cells do not respond properly to insulin (known as Type 2 diabetes), or both. Approximately 10% of all diabetes cases are Type 1, and approximately 90% of all cases of diabetes worldwide are of Type 2.

Top Leading Manufactures-

Novo Nordisk, Sanofi, Eli Lilly, Takeda, Pfizer, Janssen Pharmaceuticals, Astellas, Boehringer Ingelheim, Merck and Co., AstraZeneca, Bristol Myers Squibb, Novartis

Market Scenario

Key Market Trends - Rising Prevalence of Diabetes

As per a WHO report, the global prevalence of diabetes among adults of over 18 years had accelerated from about 4.7%, in 1980, to over 8.5%, in 2014.
Diabetes prevalence has been rising rapidly in the middle- and low-income countries. In 2015, about 1.6 million deaths were directly associated with diabetes, which was around 2.2 million in 2012.
Almost half of all deaths attributable to high blood glucose occur before the age of 70 years. WHO projects that diabetes is likely to be the seventh leading cause of death by 2030.
Statistics prove that one in ten individuals in the world has diabetes and a rise in this trend is expected to take the situation to one in three by 2050 (according to the Center for Disease Control and Prevention).
The growing prevalence of diabetes is the major driver for the global diabetes care drugs market. Additionally, rising awareness regarding diabetes care, the growing prevalence of obesity, and technological advancements are further driving the market.

Inquire for Discount:

https://www.marketinsightsreports.com/reports/04021169140/diabetes-care-drugs-market-2012-2024/discount?Mode=21

What are the market factors that are explained in the report?

–Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a Global and regional scale.

–Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

–Analytical Tools: Global Diabetes Care Drugs Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, feasibility study, and investment return analysis have been used to analyzed the growth of the key players operating in the market. 

Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234
Mob: +91-750-707-8687
sales@marketinsightsreports.com
irfan@marketinsightsreports.com

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.